Agios Pharmaceuticals vs Fulcrum Therapeutics
AGIO and FULC side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How AGIO and FULC compare
Agios Pharmaceuticals is the larger company, worth 6.6 times as much as Fulcrum Therapeutics ($1.9B against $288M).
Agios Pharmaceuticals scores higher on the StockData Score (13 against 8 for Fulcrum Therapeutics), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | AGIO | FULC |
|---|---|---|
| Size and price | ||
| Market cap | $1.9B | $288M |
| Share price | $31.59 | $3.77 |
| Change, 1 year | −27.6% | −54.9% |
| Change, 5 years | −17.3% | −78.0% |
| Beta (5Y) | 1.41 | 1.56 |
| Employees | 539 | 55 |
| StockData Score | ||
| Total score | 13 (better) | 8 |
| Valuation score | 2 (better) | 1 |
| Growth score | 3 (better) | 0 |
| Performance score | 2 (better) | 1 |
| Health score | 6 | 6 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 13.4× | – |
| P/B | 1.9× | 1.0× (better) |
| FCF yield | −17.8% (better) | −22.7% |
| Fair value | $32.10 | – |
| Margin of safety | 1.6% | – |
| Growth | ||
| Revenue growth (TTM) | 214% | – |
| Profitability | ||
| Gross margin | 93.8% | – |
| Operating margin | −298% | – |
| Net margin | −265% | – |
| FCF margin | −239% | – |
| Return on equity | −32.9% | −30.5% (better) |
| Return on invested capital | −1169% | −41.3% (better) |
| Financial health | ||
| Debt / equity | 0.00 | 0.00 |
| Current ratio | 9.69 | 36.19 (better) |
| Altman Z-score | 11.86 | 16.95 (better) |
| Piotroski F-score | 1 | 3 (better) |
| Dividends and buybacks | ||
| Buyback yield | – | −1.5% |
| Shareholder yield | 0.00% (better) | −1.5% |
| Ownership | ||
| Held by institutions | 111% | 112% |
| Held by insiders | 1.1% | 34.7% |
| Insider net buying, 12 months | −$4.9M (better) | −$57.5M |
| Short interest, % of float | 11.1% | 12.9% |
Go deeper
- AGIO stock overview
- AGIO income statement
- AGIO valuation and score
- FULC stock overview
- FULC income statement
- FULC valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.